Ginkgo Bioworks Holdings Inc

DNA04 Dec 2024
Healthcare
$9.71
-0.02 (-1.88%)
Lowest Today
$9.44
Highest Today
$9.99
Today’s Open
$9.71
Prev. Close
$9.73
52 Week High
$75.2
52 Week Low
$5.26
To Invest in Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc

Healthcare
DNA04 Dec 2024
-0.02 (-1.88%)
1M
3M
6M
1Y
5Y
Low
$9.44
Day’s Range
High
$9.99
9.44
52 Week Low
$5.26
52-Week Range
52 Week High
$75.2
5.26
1 Day
-
1 Week
+17.86%
1 month return
+27.35%
3 month return
+56.17%
6 month return
+1744.54%
1 Year return
+590.07%
3 Years return
-0.2%
5 Years return
-
10 Years return
-
Institutional Holdings
BlackRock Inc
73.09
NORGES BANK
27.19
MS INVF US Growth I
11.97
Jane Street Group LLC
8.67
Nikko Gbl All Biological Genome Eq MF
8.65
Viking Global Investors LP
6.22
Baillie Gifford & Co Limited.
5.84

Market Status

Fundamentals
Market Cap
552.37 mln
PB Ratio
0.69
PE Ratio
0
Enterprise Value
381.75 mln
Total Assets
1665.34 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Organisation
Ginkgo Bioworks Holdings Inc
Employees
1218
Industry
Biotechnology
CEO
Dr. Jason  Kelly Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step